Association of AGTR1 A1166C and CYP2C9∗3 Gene Polymorphisms with the Antihypertensive Effect of Valsartan.
Yi LiuXiaomu KongYongwei JiangMeimei ZhaoPeng GaoXiao CongYongtong CaoLiang MaPublished in: International journal of hypertension (2022)
A1166 C polymorphism may be associated with the antihypertensive effect of valsartan, and carriers with AC and CC genotypes may have a better antihypertensive efficacy response to valsartan treatment.